Intensive Glycemic Control May Cut CV Autonomic Neuropathy Risk
Greatest CAN prevention effect seen among type 2 diabetes patients without cardiovascular disease history
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.